4366

Daito Chemix Corporation

ダイトーケミックス

Industry
Chemicals
Market
Standard
Accounting standards
Japanese GAAP
Consolidation basis
Consolidated

Key metrics

Revenue(million JPY)

Mar 2021
13,998
Mar 2022
16,134
Mar 2023
16,377
Mar 2024
15,811
Mar 2025
18,644

Operating profit(million JPY)

Mar 2021
1,443
Mar 2022
1,763
Mar 2023
1,283
Mar 2024
776
Mar 2025
848

Operating profit margin(%)

Mar 2021
10.31
Mar 2022
10.93
Mar 2023
7.83
Mar 2024
4.91
Mar 2025
4.55

Profit before tax(million JPY)

Mar 2021
1,231
Mar 2022
1,751
Mar 2023
1,291
Mar 2024
-678
Mar 2025
853

Profit(million JPY)

Mar 2021
1,092
Mar 2022
1,583
Mar 2023
922
Mar 2024
-1,005
Mar 2025
820

Total assets(million JPY)

Mar 2021
18,825
Mar 2022
21,535
Mar 2023
24,698
Mar 2024
24,980
Mar 2025
24,330

Cash and cash equivalents(million JPY)

Mar 2021
3,254
Mar 2022
3,423
Mar 2023
2,394
Mar 2024
2,252
Mar 2025
2,775

Cash flows from operating activities(million JPY)

Mar 2021
2,526
Mar 2022
1,150
Mar 2023
404
Mar 2024
1,048
Mar 2025
2,746

Cash flows from investing activities(million JPY)

Mar 2021
-376
Mar 2022
-1,525
Mar 2023
-1,997
Mar 2024
-2,674
Mar 2025
-1,194

Cash flows from financing activities(million JPY)

Mar 2021
-281
Mar 2022
543
Mar 2023
563
Mar 2024
1,483
Mar 2025
-1,029

Return on equity(%)

Mar 2021
9
Mar 2022
11.7
Mar 2023
6.3
Mar 2024
-
Mar 2025
5.6

Equity ratio(%)

Mar 2021
67.8
Mar 2022
66.3
Mar 2023
61.4
Mar 2024
58.2
Mar 2025
61.1

Earnings per share(JPY per share)

Mar 2021
101.75
Mar 2022
147.5
Mar 2023
85.96
Mar 2024
-93.7
Mar 2025
76.41

Net assets per share(JPY per share)

Mar 2021
1,188.42
Mar 2022
1,330.59
Mar 2023
1,413.6
Mar 2024
1,354.04
Mar 2025
1,383.74

Dividend per share(JPY per share)

Mar 2021
12
Mar 2022
14
Mar 2023
12
Mar 2024
10
Mar 2025
16

Payout ratio(%)

Mar 2021
11.79
Mar 2022
9.49
Mar 2023
13.96
Mar 2024
-
Mar 2025
20.94

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.